Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-04-06

Opinion for Teva Pharmaceutical (TEVA-N)

Signal Price Bias Subject Owned
DON'T BUY $32.350 UNKNOWN NORTH AMERICAN - LARGE & ETFs Unknown

The 200 day, 50 day and 100 day moving averages have all fallen. The price is below those averages, so there hasn’t been a breakthrough. However, there seems to be a bit of a basing pattern over the last few months. Is it going to start the shares rebounding? It’s hard to say. It could be a bit of a value trap at this point.

Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod http://www.stanwong.com

1 Comment

idaustin

April 23rd 2017 at 8:28am

Mr Wong's moving averages told him it was a value trap. They whispered to him while he was sleeping.


You must be logged in to comment.